Clinical Trials on Hyperplasia Prostatic in Poland
Total 523 results
-
NYU Langone HealthNovartisCompletedProstatic Neoplasms | Prostate CancerUnited States
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
DendreonCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; Northwestern University; Oregon Health and Science UniversityActive, not recruiting
-
OHSU Knight Cancer InstituteAstellas Pharma US, Inc.; Oregon Health and Science UniversityActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7United States
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
Lava TherapeuticsMerck Sharp & Dohme LLCRecruitingMetastatic Castration Resistant Prostate CancerUnited States, Spain, Netherlands
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Novartis PharmaceuticalsCompletedProstate CancerCanada, United States
-
IpsenTerminatedProstate CancerUnited Kingdom, Spain, France, Belgium, Poland, Latvia, Lithuania, Ukraine
-
Hookipa Biotech GmbHTerminatedProstate Cancer MetastaticUnited States
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingProstate Cancer | Hormone-Dependent Prostate CancerChina, Czechia, Poland, Bulgaria
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, United States, Spain, France, Belgium, China, Taiwan, United Kingdom, Australia, Czechia, Hungary, Poland, Russian Federation
-
Astellas Pharma Global Development, Inc.PfizerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerUnited States
-
VA Office of Research and DevelopmentSanofiCompletedProstate CancerUnited States, Puerto Rico
-
OHSU Knight Cancer InstituteOregon Health and Science University; Blue Earth DiagnosticsRecruitingProstate CancerUnited States
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
European Organisation for Research and Treatment...CompletedProstate Cancer | Metastatic CancerNetherlands, Denmark, Belgium, Poland, Switzerland, United Kingdom, Italy, Russian Federation, Portugal
-
AmgenUnknownPain | Prostate CancerUnited States
-
Spanish Oncology Genito-Urinary GroupApices Soluciones S.L.; Janssen, LPCompleted
-
Bristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | PSA Progression | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of TestosteroneUnited States
-
Bristol-Myers SquibbTerminated
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Aragon Pharmaceuticals, Inc.Completed
-
CureVacTerminatedTrial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate CancerProstate CancerFrance, Czech Republic, Germany, Poland, Spain, Sweden, Switzerland, United Kingdom
-
Brown UniversityThe Miriam HospitalCompletedProstate CancerUnited States
-
US Oncology ResearchPfizerCompleted
-
Harpoon TherapeuticsTerminatedAdvanced Prostate CancerUnited States, United Kingdom
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
Achieve Life SciencesTeva Pharmaceuticals USATerminatedHormone Refractory Prostate Cancer | Castrate-Resistant Prostate CancerFrance, United States, Spain, United Kingdom, Canada
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
AbbVieRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Israel, Australia
-
VA Office of Research and DevelopmentRecruitingMetastatic Prostate CancerUnited States
-
BayerCompletedProstate CancerUnited States, Argentina
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Australia, France, Germany, Spain, Bulgaria, Estonia, Italy, Poland, Netherlands, Belgium, United Kingdom, Canada, Denmark, Ukraine, Finland, Latvia, Russian Federation, Greece, Slovenia, Brazil, Mexico, Slovakia, Japan, Puerto... and more
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Ionis Pharmaceuticals, Inc.CompletedCastrate-Resistant Prostate CancerUnited States, Puerto Rico, Hungary, Romania, Russian Federation, Poland
-
Eli Lilly and CompanyCompletedProstate CancerBelgium, Germany, Spain, Poland, Czechia, Hungary, Italy
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Incyte CorporationTerminatedProstate CancerUnited States
-
University Medical Center GroningenDutch Cancer SocietyRecruitingAndrogen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy (ADOPT)Prostate CancerNetherlands
-
University of Michigan Rogel Cancer CenterNational Institutes of Health (NIH); Myrexis Inc.; Veracyte, Inc.; MDx HealthRecruiting